Waters Past Earnings Performance

Past criteria checks 2/6

Waters has been growing earnings at an average annual rate of 3.3%, while the Life Sciences industry saw earnings growing at 11.7% annually. Revenues have been growing at an average rate of 5.5% per year. Waters's return on equity is 38.8%, and it has net margins of 21.4%.

Key information

3.3%

Earnings growth rate

5.8%

EPS growth rate

Life Sciences Industry Growth21.5%
Revenue growth rate5.5%
Return on equity38.8%
Net Margin21.4%
Last Earnings Update28 Sep 2024

Recent past performance updates

Recent updates

Is Waters (NYSE:WAT) A Risky Investment?

Nov 21
Is Waters (NYSE:WAT) A Risky Investment?

Waters Corp: Short Reinvestment Runway Diminishes High Multiples

Nov 13

Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings

Sep 11
Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings

A Look At The Fair Value Of Waters Corporation (NYSE:WAT)

Aug 24
A Look At The Fair Value Of Waters Corporation (NYSE:WAT)

Waters Corp.: Embedded Expectations High Under Present Conditions

Aug 15

Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?

Aug 06
Does Waters (NYSE:WAT) Have A Healthy Balance Sheet?

Should You Think About Buying Waters Corporation (NYSE:WAT) Now?

Jul 19
Should You Think About Buying Waters Corporation (NYSE:WAT) Now?

Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price

May 26
Waters Corporation's (NYSE:WAT) Business Is Yet to Catch Up With Its Share Price

Waters Corporation: Still Struggling A Bit

May 24

Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Apr 25
Estimating The Intrinsic Value Of Waters Corporation (NYSE:WAT)

Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?

Apr 07
Is It Too Late To Consider Buying Waters Corporation (NYSE:WAT)?

We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt

Mar 19
We Think Waters (NYSE:WAT) Can Stay On Top Of Its Debt

Waters Corporation: A Great (Share Price) Run

Mar 11

Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323

Feb 09
Waters Corporation (NYSE:WAT) Released Earnings Last Week And Analysts Lifted Their Price Target To US$323

Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings

Jan 09
Waters Corporation's (NYSE:WAT) Price Is Out Of Tune With Earnings

Waters Corporation: High Quality Niche Company In Mass Spectrometry

Dec 28

Waters Corporation: Appealing Levels Are Offset By Weaker Performance

Nov 13

Waters Corporation: Buybacks Ceased, Incremental Returns Languishing (Rating Downgrade)

Sep 27

Waters Corporation: Temporary Headwinds Present A Buying Opportunity

Jul 18

Waters Q4 2022 Earnings Preview

Feb 14

Waters Corp.: Now Best Price-Positioned Medical Services Stock

Feb 02

Waters Corporation: Tactical Buy Seeking Upside Objectives Of $345, $363

Nov 16

Waters Q3 2022 Earnings Preview

Oct 31

Waters announces €6M R&D investment at Wexford facility

Oct 07

Waters Corporation: Thesis Unchanged

Aug 18

Revenue & Expenses Breakdown

How Waters makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

NYSE:WAT Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
28 Sep 242,905623690180
29 Jun 242,877596688177
30 Mar 242,909604690177
31 Dec 232,956642697175
30 Sep 232,995653690179
01 Jul 232,992675696180
01 Apr 232,966689682178
31 Dec 222,972708658176
01 Oct 222,950697658171
02 Jul 222,901702645170
02 Apr 222,868705641171
31 Dec 212,786693627168
02 Oct 212,736695606165
03 Jul 212,671660563158
03 Apr 212,509616541144
31 Dec 202,365522555141
26 Sep 202,295504507138
27 Jun 202,278515524138
28 Mar 202,358537522143
31 Dec 192,407592526143
28 Sep 192,405577582144
29 Jun 192,406580584145
30 Mar 192,403591589144
31 Dec 182,420594585143
29 Sep 182,39255543140
30 Jun 182,38051550139
31 Mar 182,34227540136
31 Dec 172,30920545133
30 Sep 172,251548512130
01 Jul 172,212537501127
01 Apr 172,190533502127
31 Dec 162,167522512125
01 Oct 162,125498508121
02 Jul 162,099490509121
02 Apr 162,057467502119
31 Dec 152,042469493119
03 Oct 152,040469498119
04 Jul 152,032467496116
04 Apr 152,019457501112
31 Dec 141,989432502108
27 Sep 141,971422501106
28 Jun 141,935406500102
29 Mar 141,904399495100
31 Dec 131,904450493101

Quality Earnings: WAT has high quality earnings.

Growing Profit Margin: WAT's current net profit margins (21.4%) are lower than last year (21.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: WAT's earnings have grown by 3.3% per year over the past 5 years.

Accelerating Growth: WAT's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: WAT had negative earnings growth (-4.7%) over the past year, making it difficult to compare to the Life Sciences industry average (-4.7%).


Return on Equity

High ROE: Whilst WAT's Return on Equity (38.84%) is high, this metric is skewed due to their high level of debt.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 11:06
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/28
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Waters Corporation is covered by 43 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Charles ButlerBarclays
Luke SergottBarclays